Asymchem

Asymchem Laboratories is a premier CDMO offering integrated services across the drug development lifecycle, from preclinical to commercial manufacturing. The company has established itself as a leader in advanced technologies, particularly in continuous flow chemistry and biocatalysis, serving a global client base of innovative biopharma companies. With multiple FDA-inspected facilities in China and a growing international presence, Asymchem supports the development of complex therapeutics across various therapeutic areas. Its strategic focus on technology-driven solutions and quality excellence positions it as a critical partner in the global pharmaceutical supply chain.

A globally recognized leader in continuous flow chemistry and integrated technologies for complex small molecule development and manufacturing, offering biocatalysis, green chemistry solutions, and high-potency API (HPAPI) capabilities.

Total raised: $290M

Asymchem competes with large global CDMOs like Lonza and Catalent, small molecule specialists like Cambrex, and regional Asian leaders like WuXi AppTec. Its primary differentiation is its recognized technological leadership, particularly in continuous flow chemistry, allowing it to win complex, high-value projects rather than competing on cost alone for standard chemistry.